Fibrous Dysplasia of Bone
📧 Sign up to get email alerts when something new happens for Fibrous Dysplasia of Bone.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Assessment of Femoral Failure Load and Fracture Risk in Rare Bone Disorders Using MEKANOS Tool. Case Study of Fibrous Dysplasia of Bone/McCune Albright Syndrome
This clinical trial update describes evaluating femoral failure load and fracture risk in rare bone disorders using the MEKANOS tool. It inc…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study [NA]
This ClinicalTrials.gov update describes the exploratory pilot study PAINDYS to characterize pain in fibrous dysplasia of bone and McCune-Al…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia [Phase 2]
A Phase 2 trial evaluating burosumab for FGF23-mediated hypophosphatemia in fibrous dysplasia has completed and posted its results.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia [NA]
The clinical trial investigating serum periostin dosage in patients with fibrous dysplasia of bone has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE [Phase 2]
A Phase 2 clinical trial evaluating tocilizumab for fibrous dysplasia of bone has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Epigenetic Regulation in Fibrous Dysplasia of Bone: mirDYS Study. [NA]
A clinical trial update for the mirDYS study investigating epigenetic regulation in fibrous dysplasia of bone. The trial status is completed…
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone [Phase 2, Phase 3]
Phase 2/3 trial evaluating the effect of risedronate on bone morbidity in fibrous dysplasia of bone has been completed.